KYBELLA® in Denver & Aurora, CO
Submental fullness sometimes referred to as “double chin”, is a common yet undertreated facial aesthetic condition. It can impact a broad range of adults, including both men and women, and can be influenced by several factors such as aging, genetics and weight gain, and is often resistant to diet and exercise alone.
If you’re bothered by submental fullness, you’re not alone. According to a 2015 survey conducted by the American Society for Dermatologic Surgery (ASDS):
- 67% of people said they’re bothered by under-the-chin fullness or double chin
- People are just as bothered by under-the-chin fullness as they are by lines and wrinkles around and under their eyes
What is KYBELLA®?
KYBELLA® is a prescription medicine used in adults to improve the appearance and profile of moderate to severe fat below the chin (submental fat), also called “double chin.”
WHAT TO EXPECT
KYBELLA® (deoxycholic acid) injection is the first and only FDA-approved injectable treatment that contours and improves the appearance of submental fullness, sometimes referred to as “double chin”.
You and your practitioner will design a treatment plan tailored to help you improve your chin profile. During your treatment sessions, your healthcare provider will administer KYBELLA® into the fat under your chin using multiple injections. Many patients experience visible results in 2 to 4 treatment sessions. Up to 6 treatment sessions may be administered spaced no less than one month apart.
HOW IT WORKS
The active ingredient in KYBELLA® is deoxycholic acid, a naturally-occurring molecule in the body that aids in the breakdown and absorption of dietary fat.
When injected into the fat beneath your chin, KYBELLA® causes the destruction of fat cells through osmotic lysis, where water is forced into the fat cell until it explodes. Once destroyed, those cells cannot store or accumulate fat. This means your results are permanent!
You and your injector will decide how many treatments you need. Once the desired aesthetic response is achieved with KYBELLA®, retreatment is not expected.